Business Context and Reporting Period
This Form 6-K filing by Maris Tech Ltd. covers the period from December 31, 2025, through June 10, 2026. The report details capital raising transactions and provides an update on the Company's compliance with Nasdaq shareholders' equity requirements.
Key Financial Metrics and Capital Transactions
The filing focuses on equity and debt transactions rather than operational financial performance metrics such as revenue or operating cash flow.
- Registered Direct Offering (March 2026): Issued 882,825 Ordinary Shares at $1.24/share and pre-funded warrants for 722,311 shares at $1.2399/warrant. Gross proceeds were approximately $2.0 million.
- Convertible Promissory Notes: Originally issued $2.0 million in notes in November 2025. On May 29, 2026, the conversion date for the remaining $1.0 million principal was accelerated. As of June 1, 2026, the full $2.0 million principal was converted into 100,000 Ordinary Shares and pre-funded warrants for 2,165,776 shares.
- At-the-Market (ATM) Offering: Under a program allowing up to $3,007,329 in sales, the Company sold 630,674 Ordinary Shares as of June 7, 2026, generating approximately $923,000 in gross proceeds.
- Shareholders' Equity: The Company states its shareholders' equity is currently in excess of the $2,500,000 minimum Nasdaq requirement.
Note: The filing text does not provide clear values for revenue, profit, operating cash flow, or specific debt balances outside of the converted notes.
Material Changes and Compliance Status
The primary material change is the significant increase in share count and equity capital resulting from the registered direct offering, the full conversion of convertible notes, and ATM sales. These actions were taken to ensure compliance with Nasdaq listing standards.
The Company notes that Nasdaq will continue to monitor compliance. If the Company fails to evidence compliance with the shareholders' equity requirement in its interim financial statements for the six months ended June 30, 2026, its securities may be subject to delisting.
Outlook, Risks, and Contingencies
Risks: The primary risk identified is potential delisting from Nasdaq if the Company cannot demonstrate continued compliance with the $2.5 million shareholders' equity requirement in its upcoming interim financial statements.
Unusual Items: The acceleration of the conversion date for the remaining $1.0 million of convertible notes from the original twelve-month term to May 29, 2026, represents a material change in the terms of the debt instrument.
Investor Verification Checklist
- Verify the exact number of outstanding shares and the dilution impact of the 100,000 shares and 2,165,776 pre-funded warrants issued upon note conversion.
- Confirm the Company's shareholders' equity balance in the upcoming interim financial statements for the period ended June 30, 2026, to assess delisting risk.
- Review the remaining capacity under the At-the-Market offering program ($3,007,329 total limit minus $923,000 sold).
- Examine the full text of the Securities Purchase Agreement and Note Purchase Agreements (Exhibits 10.1, 10.2, 10.3) for specific covenants and conversion mechanics.